Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$197.69 - $227.29 $30,048 - $34,548
-152 Reduced 7.44%
1,890 $430,000
Q3 2023

Nov 02, 2023

BUY
$201.05 - $221.7 $410,544 - $452,711
2,042 New
2,042 $410,000
Q4 2022

Feb 09, 2023

BUY
$203.72 - $248.97 $199,034 - $243,243
977 New
977 $230,000
Q2 2022

Aug 03, 2022

SELL
$213.86 - $277.87 $174,082 - $226,186
-814 Closed
0 $0
Q1 2022

May 03, 2022

BUY
$259.82 - $298.18 $35,075 - $40,254
135 Added 19.88%
814 $215,000
Q4 2021

Feb 01, 2022

BUY
$271.6 - $314.21 $184,416 - $213,348
679 New
679 $213,000
Q3 2021

Oct 08, 2021

SELL
$274.82 - $308.34 $264,102 - $296,314
-961 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$251.87 - $278.14 $19,393 - $21,416
77 Added 8.71%
961 $265,000
Q1 2021

Apr 14, 2021

BUY
$204.88 - $255.03 $135,015 - $168,064
659 Added 292.89%
884 $225,000
Q1 2021

Apr 13, 2021

SELL
$204.88 - $255.03 $351,164 - $437,121
-1,714 Reduced 88.4%
225 $57,000
Q4 2020

Feb 08, 2021

SELL
$186.91 - $214.42 $10,093 - $11,578
-54 Reduced 2.71%
1,939 $395,000
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $13,863 - $16,707
-83 Reduced 4.0%
1,993 $375,000
Q2 2020

Jul 22, 2020

SELL
$113.31 - $182.44 $79,317 - $127,708
-700 Reduced 25.22%
2,076 $345,000
Q1 2020

May 22, 2020

SELL
$104.32 - $195.28 $31.1 Million - $58.2 Million
-298,006 Reduced 99.08%
2,776 $351,000
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $31.1 Million - $58.3 Million
298,516 Added 13173.7%
300,782 $503,000
Q4 2019

Feb 12, 2020

BUY
$163.48 - $173.61 $370,445 - $393,400
2,266 New
2,266 $383,000
Q3 2019

Nov 07, 2019

SELL
$159.77 - $178.1 $401,022 - $447,031
-2,510 Closed
0 $0
Q2 2019

Jul 19, 2019

SELL
$144.16 - $172.9 $48,293 - $57,921
-335 Reduced 11.78%
2,510 $434,000
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $242,946 - $306,973
-1,964 Reduced 40.84%
2,845 $435,000
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $185,700 - $267,576
-1,537 Reduced 24.22%
4,809 $608,000
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $91,547 - $102,795
546 Added 9.41%
6,346 $1.1 Million
Q2 2018

Aug 08, 2018

SELL
$160.33 - $189.41 $2.71 Million - $3.2 Million
-16,884 Reduced 74.43%
5,800 $1.04 Million
Q1 2018

May 02, 2018

SELL
$161.53 - $178.11 $166,214 - $183,275
-1,029 Reduced 4.34%
22,684 $3.67 Million
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $249,511 - $276,419
1,686 Added 7.65%
23,713 $3.78 Million
Q3 2017

Nov 03, 2017

SELL
$149.47 - $160.56 $321,808 - $345,685
-2,153 Reduced 8.9%
22,027 $3.33 Million
Q2 2017

Aug 11, 2017

BUY
N/A
24,180
24,180 $3.73 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.